{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:40Z","timestamp":1787772640513,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Several phyto-chemicals have been identified and suggested as potential therapeutic options for hepatotoxicity management<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To assess the hepatoprotective effect of scopoletin, a pure phyto-chemical, in carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      )-induced hepatotoxicity model in Wistar rats\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Thirty-six rats in total, six in each group, were utilized in this study. Animals in group 1 received normal saline; those in group 2 received carbon tetrachloride in olive oil (0.5 ml\/kg, i.p. in ratio 1:1); those in groups 3, 4, and 5 received oral scopoletin (1 mg\/kg, 5 mg\/kg, 10 mg\/kg dose-wise groups); and those in group 6 received N-acetyl cysteine (NAC) 150 mg\/kg. Blood sampling was performed on day -3, day 1, and day 7 of the CCl\n                      <jats:sub>4<\/jats:sub>\n                      administration. Rats were sacrificed on day 7 of the experiment for histological examination and oxidative stress measurement of the liver\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The 5 mg\/kg scopoletin group showed a maximum reduction in AST levels [727.33 \u00b1 29.15 in medium dose (MD) group vs 1526.66 \u00b1 60.72 in the experimental control (EC) group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and ALT levels of 532.66 \u00b1 24.23 in MD group vs 894.83 \u00b1 52.47 in EC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01)]. The dose-dependent action was not observed with scopoletin doses. The protective effect of scopoletin was confirmed by MDA and GSH levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) coupled with histo-pathological findings. In the present study, a reversible model of CCl\n                      <jats:sub>4<\/jats:sub>\n                      -induced hepatotoxicity was observed to get normalized in a week\u2019s time\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study confirms the hepatoprotective action of scopoletin in an acute model of hepatic injury with the putative anti-oxidant mechanism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_333_22","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:31:26Z","timestamp":1676439086000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological Evaluation of Scopoletin in the Carbon Tetrachloride- Induced Hepatotoxicity Model in Wistar Rats"],"prefix":"10.4103","volume":"14","author":[{"given":"Swati","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyajyoti","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol N.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240829","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12072-017-9793-2","article-title":"CSH guidelines for the diagnosis and treatment of drug-induced liver injury","volume":"11","author":"Yu","year":"2017","journal-title":"Hepatol Int"},{"key":"R2-7-20240829","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"R3-7-20240829","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3390\/toxins2092289","article-title":"Naturally occurring food toxins","volume":"2","author":"Dolan","year":"2010","journal-title":"Toxins"},{"key":"R4-7-20240829","doi-asserted-by":"crossref","first-page":"e0196411","DOI":"10.1371\/journal.pone.0196411","article-title":"Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill","volume":"13","author":"Dutta","year":"2018","journal-title":"PLoS One"},{"key":"R6-7-20240829","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/antiox10060967","article-title":"N-Acetylcysteine (NAC): Impacts on human health","volume":"10","author":"Ten\u00f3rio MC dos","year":"2021","journal-title":"Antioxidants"},{"key":"R7-7-20240829","doi-asserted-by":"crossref","first-page":"282","DOI":"10.9758\/cpn.2021.19.2.282","article-title":"Effectiveness of N-acetylcysteine in treating clinical symptoms of substance abuse and dependence: A meta-analysis of randomized controlled trials","volume":"19","author":"Chang","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R8-7-20240829","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/jphp.13004","article-title":"Pharmacological evaluation of Convolvulus pluricaulis as hypolipidaemic agent in Triton WR-1339-induced hyperlipidaemia in rats","volume":"70","author":"Garg","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"R9-7-20240829","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaim.2020.06.011","article-title":"Protective role of Convolvulus pluricaulis on lipid abnormalities in high-fat diet with low dose streptozotocin-induced experimental rat model","volume":"11","author":"Garg","year":"2020","journal-title":"J Ayurveda Integr Med"},{"key":"R10-7-20240829","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2221-1691(14)60240-9","article-title":"An update on Ayurvedic herb Convolvulus pluricaulis Choisy","volume":"4","author":"Agarwa","year":"2014","journal-title":"Asian Pac J Trop Biomed"},{"key":"R11-7-20240829","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2020.00171","article-title":"Phytochemical profile, pharmacological attributes and medicinal properties of Convolvulus prostratus \u2013A cognitive enhancer herb for the management of neurodegenerative etiologies","volume":"11","author":"Balkrishna","year":"2020","journal-title":"Front Pharmacol"},{"key":"R12-7-20240829","first-page":"74","article-title":"An update on treatment of drug-induced liver injury","volume":"2","author":"Giordano","year":"2014","journal-title":"J Clin Transl Hepatol"},{"key":"R13-7-20240829","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1472-6882-12-178","article-title":"CCl4-induced hepatotoxicity: Protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat","volume":"12","author":"Khan","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"R14-7-20240829","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","article-title":"N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: Role of liver transforming growth factor-beta and oxidative stress","volume":"21","author":"Galicia-Moreno","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-7-20240829","doi-asserted-by":"crossref","first-page":"595603","DOI":"10.1155\/2012\/595603","article-title":"Ameliorative effects of scopoletin from crossostephium chinensis against inflammation pain and its mechanisms in mice","volume":"2012","author":"Chang","year":"2012","journal-title":"Evid Based Complement Altern Med"},{"key":"R16-7-20240829","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0940-2993(11)80116-8","article-title":"Olive oil decreases liver damage in rats caused by carbon tetrachloride (CCl4)","volume":"46","author":"Szende","year":"1994","journal-title":"Exp Toxicol Pathol"},{"key":"R17-7-20240829","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1043-6618(02)00121-4","article-title":"Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: Inhibition of cytochrome P450 2E1 expression","volume":"46","author":"Jeong","year":"2002","journal-title":"Pharmacol Res"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_333_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:09Z","timestamp":1787771229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_333_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_333_22","relation":{},"ISSN":["0976-4879"],"issn-type":[{"value":"0976-4879","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}